COVID-19 Impact on Global Weight Loss Therapeutics Market Size, Status and Forecast 2020-2026
Currently, available weight loss mainly therapeutics works by appetite suppression, increasing body metabolism and interfering with the digestion and absorption patterns.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Weight Loss Therapeutics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Weight Loss Therapeutics industry.
Based on our recent survey, we have several different scenarios about the Weight Loss Therapeutics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Weight Loss Therapeutics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Weight Loss Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Weight Loss Therapeutics market in terms of revenue.
Players, stakeholders, and other participants in the global Weight Loss Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Weight Loss Therapeutics market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Weight Loss Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Weight Loss Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Weight Loss Therapeutics market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Weight Loss Therapeutics market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Weight Loss Therapeutics industry.
Based on our recent survey, we have several different scenarios about the Weight Loss Therapeutics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Weight Loss Therapeutics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Weight Loss Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Weight Loss Therapeutics market in terms of revenue.
Players, stakeholders, and other participants in the global Weight Loss Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Weight Loss Therapeutics market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Weight Loss Therapeutics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Weight Loss Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Weight Loss Therapeutics market.
The following players are covered in this report:
- Abbott
- Sanofi
- Novo Nordisk
- Arena Pharmaceuticals
- Orexigen Therapeutics
- Johnson & Johnson
- Pfizer
- Novartis AG
- Biocon
- VIVUS
- Eli Lilly
- Amgen
- Zafgen
- Roche
- Eisai
- Appetite Suppression
- Increasing Body Metabolism
- Interfering with the Digestion Absorption Patterns
- Hospitals
- Specialized Clinics
- Retail Pharmacies
- Mail Order Pharmacies
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Weight Loss Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Weight Loss Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Appetite Suppression
1.4.3 Increasing Body Metabolism
1.4.4 Interfering with the Digestion Absorption Patterns
1.5 Market by Application
1.5.1 Global Weight Loss Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialized Clinics
1.5.4 Retail Pharmacies
1.5.5 Mail Order Pharmacies
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Weight Loss Therapeutics Industry Impact
1.6.1 How the Covid-19 is Affecting the Weight Loss Therapeutics Industry
1.6.1.1 Weight Loss Therapeutics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Weight Loss Therapeutics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Weight Loss Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Weight Loss Therapeutics Market Perspective (2015-2026)
2.2 Weight Loss Therapeutics Growth Trends by Regions
2.2.1 Weight Loss Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Weight Loss Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Weight Loss Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Weight Loss Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Weight Loss Therapeutics Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Weight Loss Therapeutics Players by Market Size
3.1.1 Global Top Weight Loss Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Weight Loss Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Weight Loss Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Weight Loss Therapeutics Market Concentration Ratio
3.2.1 Global Weight Loss Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Weight Loss Therapeutics Revenue in 2019
3.3 Weight Loss Therapeutics Key Players Head office and Area Served
3.4 Key Players Weight Loss Therapeutics Product Solution and Service
3.5 Date of Enter into Weight Loss Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Weight Loss Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Weight Loss Therapeutics Forecasted Market Size by Type (2021-2026)
5 WEIGHT LOSS THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Weight Loss Therapeutics Market Size by Application (2015-2020)
5.2 Global Weight Loss Therapeutics Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Weight Loss Therapeutics Market Size (2015-2020)
6.2 Weight Loss Therapeutics Key Players in North America (2019-2020)
6.3 North America Weight Loss Therapeutics Market Size by Type (2015-2020)
6.4 North America Weight Loss Therapeutics Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Weight Loss Therapeutics Market Size (2015-2020)
7.2 Weight Loss Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Weight Loss Therapeutics Market Size by Type (2015-2020)
7.4 Europe Weight Loss Therapeutics Market Size by Application (2015-2020)
8 CHINA
8.1 China Weight Loss Therapeutics Market Size (2015-2020)
8.2 Weight Loss Therapeutics Key Players in China (2019-2020)
8.3 China Weight Loss Therapeutics Market Size by Type (2015-2020)
8.4 China Weight Loss Therapeutics Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Weight Loss Therapeutics Market Size (2015-2020)
9.2 Weight Loss Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Weight Loss Therapeutics Market Size by Type (2015-2020)
9.4 Japan Weight Loss Therapeutics Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Weight Loss Therapeutics Market Size (2015-2020)
10.2 Weight Loss Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Weight Loss Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Weight Loss Therapeutics Market Size by Application (2015-2020)
11 INDIA
11.1 India Weight Loss Therapeutics Market Size (2015-2020)
11.2 Weight Loss Therapeutics Key Players in India (2019-2020)
11.3 India Weight Loss Therapeutics Market Size by Type (2015-2020)
11.4 India Weight Loss Therapeutics Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Weight Loss Therapeutics Market Size (2015-2020)
12.2 Weight Loss Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Weight Loss Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Weight Loss Therapeutics Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Weight Loss Therapeutics Introduction
13.1.4 Abbott Revenue in Weight Loss Therapeutics Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview and Its Total Revenue
13.2.3 Sanofi Weight Loss Therapeutics Introduction
13.2.4 Sanofi Revenue in Weight Loss Therapeutics Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Novo Nordisk
13.3.1 Novo Nordisk Company Details
13.3.2 Novo Nordisk Business Overview and Its Total Revenue
13.3.3 Novo Nordisk Weight Loss Therapeutics Introduction
13.3.4 Novo Nordisk Revenue in Weight Loss Therapeutics Business (2015-2020)
13.3.5 Novo Nordisk Recent Development
13.4 Arena Pharmaceuticals
13.4.1 Arena Pharmaceuticals Company Details
13.4.2 Arena Pharmaceuticals Business Overview and Its Total Revenue
13.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Introduction
13.4.4 Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2015-2020)
13.4.5 Arena Pharmaceuticals Recent Development
13.5 Orexigen Therapeutics
13.5.1 Orexigen Therapeutics Company Details
13.5.2 Orexigen Therapeutics Business Overview and Its Total Revenue
13.5.3 Orexigen Therapeutics Weight Loss Therapeutics Introduction
13.5.4 Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2015-2020)
13.5.5 Orexigen Therapeutics Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview and Its Total Revenue
13.6.3 Johnson & Johnson Weight Loss Therapeutics Introduction
13.6.4 Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview and Its Total Revenue
13.7.3 Pfizer Weight Loss Therapeutics Introduction
13.7.4 Pfizer Revenue in Weight Loss Therapeutics Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Novartis AG
13.8.1 Novartis AG Company Details
13.8.2 Novartis AG Business Overview and Its Total Revenue
13.8.3 Novartis AG Weight Loss Therapeutics Introduction
13.8.4 Novartis AG Revenue in Weight Loss Therapeutics Business (2015-2020)
13.8.5 Novartis AG Recent Development
13.9 Biocon
13.9.1 Biocon Company Details
13.9.2 Biocon Business Overview and Its Total Revenue
13.9.3 Biocon Weight Loss Therapeutics Introduction
13.9.4 Biocon Revenue in Weight Loss Therapeutics Business (2015-2020)
13.9.5 Biocon Recent Development
13.10 VIVUS
13.10.1 VIVUS Company Details
13.10.2 VIVUS Business Overview and Its Total Revenue
13.10.3 VIVUS Weight Loss Therapeutics Introduction
13.10.4 VIVUS Revenue in Weight Loss Therapeutics Business (2015-2020)
13.10.5 VIVUS Recent Development
13.11 Eli Lilly
10.11.1 Eli Lilly Company Details
10.11.2 Eli Lilly Business Overview and Its Total Revenue
10.11.3 Eli Lilly Weight Loss Therapeutics Introduction
10.11.4 Eli Lilly Revenue in Weight Loss Therapeutics Business (2015-2020)
10.11.5 Eli Lilly Recent Development
13.12 Amgen
10.12.1 Amgen Company Details
10.12.2 Amgen Business Overview and Its Total Revenue
10.12.3 Amgen Weight Loss Therapeutics Introduction
10.12.4 Amgen Revenue in Weight Loss Therapeutics Business (2015-2020)
10.12.5 Amgen Recent Development
13.13 Zafgen
10.13.1 Zafgen Company Details
10.13.2 Zafgen Business Overview and Its Total Revenue
10.13.3 Zafgen Weight Loss Therapeutics Introduction
10.13.4 Zafgen Revenue in Weight Loss Therapeutics Business (2015-2020)
10.13.5 Zafgen Recent Development
13.14 Roche
10.14.1 Roche Company Details
10.14.2 Roche Business Overview and Its Total Revenue
10.14.3 Roche Weight Loss Therapeutics Introduction
10.14.4 Roche Revenue in Weight Loss Therapeutics Business (2015-2020)
10.14.5 Roche Recent Development
13.15 Eisai
10.15.1 Eisai Company Details
10.15.2 Eisai Business Overview and Its Total Revenue
10.15.3 Eisai Weight Loss Therapeutics Introduction
10.15.4 Eisai Revenue in Weight Loss Therapeutics Business (2015-2020)
10.15.5 Eisai Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Weight Loss Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Weight Loss Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Appetite Suppression
1.4.3 Increasing Body Metabolism
1.4.4 Interfering with the Digestion Absorption Patterns
1.5 Market by Application
1.5.1 Global Weight Loss Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Specialized Clinics
1.5.4 Retail Pharmacies
1.5.5 Mail Order Pharmacies
1.5.6 Others
1.6 Coronavirus Disease 2019 (Covid-19): Weight Loss Therapeutics Industry Impact
1.6.1 How the Covid-19 is Affecting the Weight Loss Therapeutics Industry
1.6.1.1 Weight Loss Therapeutics Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Weight Loss Therapeutics Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Weight Loss Therapeutics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Weight Loss Therapeutics Market Perspective (2015-2026)
2.2 Weight Loss Therapeutics Growth Trends by Regions
2.2.1 Weight Loss Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Weight Loss Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Weight Loss Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Weight Loss Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Weight Loss Therapeutics Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Weight Loss Therapeutics Players by Market Size
3.1.1 Global Top Weight Loss Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Weight Loss Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Weight Loss Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Weight Loss Therapeutics Market Concentration Ratio
3.2.1 Global Weight Loss Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Weight Loss Therapeutics Revenue in 2019
3.3 Weight Loss Therapeutics Key Players Head office and Area Served
3.4 Key Players Weight Loss Therapeutics Product Solution and Service
3.5 Date of Enter into Weight Loss Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Weight Loss Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Weight Loss Therapeutics Forecasted Market Size by Type (2021-2026)
5 WEIGHT LOSS THERAPEUTICS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Weight Loss Therapeutics Market Size by Application (2015-2020)
5.2 Global Weight Loss Therapeutics Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Weight Loss Therapeutics Market Size (2015-2020)
6.2 Weight Loss Therapeutics Key Players in North America (2019-2020)
6.3 North America Weight Loss Therapeutics Market Size by Type (2015-2020)
6.4 North America Weight Loss Therapeutics Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Weight Loss Therapeutics Market Size (2015-2020)
7.2 Weight Loss Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Weight Loss Therapeutics Market Size by Type (2015-2020)
7.4 Europe Weight Loss Therapeutics Market Size by Application (2015-2020)
8 CHINA
8.1 China Weight Loss Therapeutics Market Size (2015-2020)
8.2 Weight Loss Therapeutics Key Players in China (2019-2020)
8.3 China Weight Loss Therapeutics Market Size by Type (2015-2020)
8.4 China Weight Loss Therapeutics Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Weight Loss Therapeutics Market Size (2015-2020)
9.2 Weight Loss Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Weight Loss Therapeutics Market Size by Type (2015-2020)
9.4 Japan Weight Loss Therapeutics Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Weight Loss Therapeutics Market Size (2015-2020)
10.2 Weight Loss Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Weight Loss Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Weight Loss Therapeutics Market Size by Application (2015-2020)
11 INDIA
11.1 India Weight Loss Therapeutics Market Size (2015-2020)
11.2 Weight Loss Therapeutics Key Players in India (2019-2020)
11.3 India Weight Loss Therapeutics Market Size by Type (2015-2020)
11.4 India Weight Loss Therapeutics Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Weight Loss Therapeutics Market Size (2015-2020)
12.2 Weight Loss Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Weight Loss Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Weight Loss Therapeutics Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview and Its Total Revenue
13.1.3 Abbott Weight Loss Therapeutics Introduction
13.1.4 Abbott Revenue in Weight Loss Therapeutics Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview and Its Total Revenue
13.2.3 Sanofi Weight Loss Therapeutics Introduction
13.2.4 Sanofi Revenue in Weight Loss Therapeutics Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Novo Nordisk
13.3.1 Novo Nordisk Company Details
13.3.2 Novo Nordisk Business Overview and Its Total Revenue
13.3.3 Novo Nordisk Weight Loss Therapeutics Introduction
13.3.4 Novo Nordisk Revenue in Weight Loss Therapeutics Business (2015-2020)
13.3.5 Novo Nordisk Recent Development
13.4 Arena Pharmaceuticals
13.4.1 Arena Pharmaceuticals Company Details
13.4.2 Arena Pharmaceuticals Business Overview and Its Total Revenue
13.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Introduction
13.4.4 Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2015-2020)
13.4.5 Arena Pharmaceuticals Recent Development
13.5 Orexigen Therapeutics
13.5.1 Orexigen Therapeutics Company Details
13.5.2 Orexigen Therapeutics Business Overview and Its Total Revenue
13.5.3 Orexigen Therapeutics Weight Loss Therapeutics Introduction
13.5.4 Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2015-2020)
13.5.5 Orexigen Therapeutics Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview and Its Total Revenue
13.6.3 Johnson & Johnson Weight Loss Therapeutics Introduction
13.6.4 Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview and Its Total Revenue
13.7.3 Pfizer Weight Loss Therapeutics Introduction
13.7.4 Pfizer Revenue in Weight Loss Therapeutics Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Novartis AG
13.8.1 Novartis AG Company Details
13.8.2 Novartis AG Business Overview and Its Total Revenue
13.8.3 Novartis AG Weight Loss Therapeutics Introduction
13.8.4 Novartis AG Revenue in Weight Loss Therapeutics Business (2015-2020)
13.8.5 Novartis AG Recent Development
13.9 Biocon
13.9.1 Biocon Company Details
13.9.2 Biocon Business Overview and Its Total Revenue
13.9.3 Biocon Weight Loss Therapeutics Introduction
13.9.4 Biocon Revenue in Weight Loss Therapeutics Business (2015-2020)
13.9.5 Biocon Recent Development
13.10 VIVUS
13.10.1 VIVUS Company Details
13.10.2 VIVUS Business Overview and Its Total Revenue
13.10.3 VIVUS Weight Loss Therapeutics Introduction
13.10.4 VIVUS Revenue in Weight Loss Therapeutics Business (2015-2020)
13.10.5 VIVUS Recent Development
13.11 Eli Lilly
10.11.1 Eli Lilly Company Details
10.11.2 Eli Lilly Business Overview and Its Total Revenue
10.11.3 Eli Lilly Weight Loss Therapeutics Introduction
10.11.4 Eli Lilly Revenue in Weight Loss Therapeutics Business (2015-2020)
10.11.5 Eli Lilly Recent Development
13.12 Amgen
10.12.1 Amgen Company Details
10.12.2 Amgen Business Overview and Its Total Revenue
10.12.3 Amgen Weight Loss Therapeutics Introduction
10.12.4 Amgen Revenue in Weight Loss Therapeutics Business (2015-2020)
10.12.5 Amgen Recent Development
13.13 Zafgen
10.13.1 Zafgen Company Details
10.13.2 Zafgen Business Overview and Its Total Revenue
10.13.3 Zafgen Weight Loss Therapeutics Introduction
10.13.4 Zafgen Revenue in Weight Loss Therapeutics Business (2015-2020)
10.13.5 Zafgen Recent Development
13.14 Roche
10.14.1 Roche Company Details
10.14.2 Roche Business Overview and Its Total Revenue
10.14.3 Roche Weight Loss Therapeutics Introduction
10.14.4 Roche Revenue in Weight Loss Therapeutics Business (2015-2020)
10.14.5 Roche Recent Development
13.15 Eisai
10.15.1 Eisai Company Details
10.15.2 Eisai Business Overview and Its Total Revenue
10.15.3 Eisai Weight Loss Therapeutics Introduction
10.15.4 Eisai Revenue in Weight Loss Therapeutics Business (2015-2020)
10.15.5 Eisai Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Weight Loss Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Weight Loss Therapeutics Revenue
Table 3. Ranking of Global Top Weight Loss Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Weight Loss Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Appetite Suppression
Table 6. Key Players of Increasing Body Metabolism
Table 7. Key Players of Interfering with the Digestion Absorption Patterns
Table 8. COVID-19 Impact Global Market: (Four Weight Loss Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Weight Loss Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Weight Loss Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Weight Loss Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Weight Loss Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Weight Loss Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Weight Loss Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Weight Loss Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Weight Loss Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Weight Loss Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Weight Loss Therapeutics Players
Table 24. Global Weight Loss Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Weight Loss Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Therapeutics as of 2019)
Table 27. Global Weight Loss Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Weight Loss Therapeutics Product Solution and Service
Table 30. Date of Enter into Weight Loss Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Weight Loss Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Weight Loss Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Weight Loss Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Weight Loss Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 40. North America Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 42. North America Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 46. Europe Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 52. China Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 54. China Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 58. Japan Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 70. India Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 72. India Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 76. Central & South America Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Product
Table 88. Sanofi Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 89. Sanofi Recent Development
Table 90. Novo Nordisk Company Details
Table 91. Novo Nordisk Business Overview
Table 92. Novo Nordisk Product
Table 93. Novo Nordisk Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 94. Novo Nordisk Recent Development
Table 95. Arena Pharmaceuticals Company Details
Table 96. Arena Pharmaceuticals Business Overview
Table 97. Arena Pharmaceuticals Product
Table 98. Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 99. Arena Pharmaceuticals Recent Development
Table 100. Orexigen Therapeutics Company Details
Table 101. Orexigen Therapeutics Business Overview
Table 102. Orexigen Therapeutics Product
Table 103. Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 104. Orexigen Therapeutics Recent Development
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 109. Johnson & Johnson Recent Development
Table 110. Pfizer Company Details
Table 111. Pfizer Business Overview
Table 112. Pfizer Product
Table 113. Pfizer Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 114. Pfizer Recent Development
Table 115. Novartis AG Business Overview
Table 116. Novartis AG Product
Table 117. Novartis AG Company Details
Table 118. Novartis AG Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 119. Novartis AG Recent Development
Table 120. Biocon Company Details
Table 121. Biocon Business Overview
Table 122. Biocon Product
Table 123. Biocon Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 124. Biocon Recent Development
Table 125. VIVUS Company Details
Table 126. VIVUS Business Overview
Table 127. VIVUS Product
Table 128. VIVUS Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 129. VIVUS Recent Development
Table 130. Eli Lilly Company Details
Table 131. Eli Lilly Business Overview
Table 132. Eli Lilly Product
Table 133. Eli Lilly Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 134. Eli Lilly Recent Development
Table 135. Amgen Company Details
Table 136. Amgen Business Overview
Table 137. Amgen Product
Table 138. Amgen Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 139. Amgen Recent Development
Table 140. Zafgen Company Details
Table 141. Zafgen Business Overview
Table 142. Zafgen Product
Table 143. Zafgen Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 144. Zafgen Recent Development
Table 145. Roche Company Details
Table 146. Roche Business Overview
Table 147. Roche Product
Table 148. Roche Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 149. Roche Recent Development
Table 150. Eisai Company Details
Table 151. Eisai Business Overview
Table 152. Eisai Product
Table 153. Eisai Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 154. Eisai Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
Table 1. Weight Loss Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Weight Loss Therapeutics Revenue
Table 3. Ranking of Global Top Weight Loss Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Weight Loss Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Appetite Suppression
Table 6. Key Players of Increasing Body Metabolism
Table 7. Key Players of Interfering with the Digestion Absorption Patterns
Table 8. COVID-19 Impact Global Market: (Four Weight Loss Therapeutics Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Weight Loss Therapeutics Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Weight Loss Therapeutics Players to Combat Covid-19 Impact
Table 13. Global Weight Loss Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Weight Loss Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Weight Loss Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Weight Loss Therapeutics Market Share by Regions (2015-2020)
Table 17. Global Weight Loss Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Weight Loss Therapeutics Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Weight Loss Therapeutics Market Growth Strategy
Table 23. Main Points Interviewed from Key Weight Loss Therapeutics Players
Table 24. Global Weight Loss Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 25. Global Weight Loss Therapeutics Market Share by Players (2015-2020)
Table 26. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Therapeutics as of 2019)
Table 27. Global Weight Loss Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Weight Loss Therapeutics Product Solution and Service
Table 30. Date of Enter into Weight Loss Therapeutics Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 33. Global Weight Loss Therapeutics Market Size Share by Type (2015-2020)
Table 34. Global Weight Loss Therapeutics Revenue Market Share by Type (2021-2026)
Table 35. Global Weight Loss Therapeutics Market Size Share by Application (2015-2020)
Table 36. Global Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. Global Weight Loss Therapeutics Market Size Share by Application (2021-2026)
Table 38. North America Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 40. North America Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. North America Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 42. North America Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. North America Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 44. Europe Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 46. Europe Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 48. Europe Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 50. China Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 51. China Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 52. China Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. China Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 54. China Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. China Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 56. Japan Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 58. Japan Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 60. Japan Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 64. Southeast Asia Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 66. Southeast Asia Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 68. India Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 69. India Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 70. India Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. India Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 72. India Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. India Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Weight Loss Therapeutics Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Weight Loss Therapeutics Market Share (2019-2020)
Table 76. Central & South America Weight Loss Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Weight Loss Therapeutics Market Share by Type (2015-2020)
Table 78. Central & South America Weight Loss Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Weight Loss Therapeutics Market Share by Application (2015-2020)
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Sanofi Company Details
Table 86. Sanofi Business Overview
Table 87. Sanofi Product
Table 88. Sanofi Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 89. Sanofi Recent Development
Table 90. Novo Nordisk Company Details
Table 91. Novo Nordisk Business Overview
Table 92. Novo Nordisk Product
Table 93. Novo Nordisk Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 94. Novo Nordisk Recent Development
Table 95. Arena Pharmaceuticals Company Details
Table 96. Arena Pharmaceuticals Business Overview
Table 97. Arena Pharmaceuticals Product
Table 98. Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 99. Arena Pharmaceuticals Recent Development
Table 100. Orexigen Therapeutics Company Details
Table 101. Orexigen Therapeutics Business Overview
Table 102. Orexigen Therapeutics Product
Table 103. Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 104. Orexigen Therapeutics Recent Development
Table 105. Johnson & Johnson Company Details
Table 106. Johnson & Johnson Business Overview
Table 107. Johnson & Johnson Product
Table 108. Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 109. Johnson & Johnson Recent Development
Table 110. Pfizer Company Details
Table 111. Pfizer Business Overview
Table 112. Pfizer Product
Table 113. Pfizer Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 114. Pfizer Recent Development
Table 115. Novartis AG Business Overview
Table 116. Novartis AG Product
Table 117. Novartis AG Company Details
Table 118. Novartis AG Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 119. Novartis AG Recent Development
Table 120. Biocon Company Details
Table 121. Biocon Business Overview
Table 122. Biocon Product
Table 123. Biocon Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 124. Biocon Recent Development
Table 125. VIVUS Company Details
Table 126. VIVUS Business Overview
Table 127. VIVUS Product
Table 128. VIVUS Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 129. VIVUS Recent Development
Table 130. Eli Lilly Company Details
Table 131. Eli Lilly Business Overview
Table 132. Eli Lilly Product
Table 133. Eli Lilly Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 134. Eli Lilly Recent Development
Table 135. Amgen Company Details
Table 136. Amgen Business Overview
Table 137. Amgen Product
Table 138. Amgen Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 139. Amgen Recent Development
Table 140. Zafgen Company Details
Table 141. Zafgen Business Overview
Table 142. Zafgen Product
Table 143. Zafgen Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 144. Zafgen Recent Development
Table 145. Roche Company Details
Table 146. Roche Business Overview
Table 147. Roche Product
Table 148. Roche Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 149. Roche Recent Development
Table 150. Eisai Company Details
Table 151. Eisai Business Overview
Table 152. Eisai Product
Table 153. Eisai Revenue in Weight Loss Therapeutics Business (2015-2020) (Million US$)
Table 154. Eisai Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Weight Loss Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Appetite Suppression Features
Figure 3. Increasing Body Metabolism Features
Figure 4. Interfering with the Digestion Absorption Patterns Features
Figure 5. Global Weight Loss Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Specialized Clinics Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Mail Order Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Weight Loss Therapeutics Report Years Considered
Figure 12. Global Weight Loss Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Weight Loss Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Weight Loss Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Weight Loss Therapeutics Market Share by Players in 2019
Figure 17. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Weight Loss Therapeutics Revenue in 2019
Figure 19. North America Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 30. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novo Nordisk Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 32. Arena Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Arena Pharmaceuticals Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 34. Orexigen Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Orexigen Therapeutics Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 36. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Johnson & Johnson Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 38. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Pfizer Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 40. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Novartis AG Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 42. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Biocon Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 44. VIVUS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. VIVUS Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 46. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Eli Lilly Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 48. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Amgen Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 50. Zafgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Zafgen Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 52. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Roche Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 54. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Eisai Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Figure 1. Global Weight Loss Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Appetite Suppression Features
Figure 3. Increasing Body Metabolism Features
Figure 4. Interfering with the Digestion Absorption Patterns Features
Figure 5. Global Weight Loss Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Specialized Clinics Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Mail Order Pharmacies Case Studies
Figure 10. Others Case Studies
Figure 11. Weight Loss Therapeutics Report Years Considered
Figure 12. Global Weight Loss Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Weight Loss Therapeutics Market Share by Regions: 2020 VS 2026
Figure 14. Global Weight Loss Therapeutics Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Weight Loss Therapeutics Market Share by Players in 2019
Figure 17. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Therapeutics as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Weight Loss Therapeutics Revenue in 2019
Figure 19. North America Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Weight Loss Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbott Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 28. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Sanofi Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 30. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novo Nordisk Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 32. Arena Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Arena Pharmaceuticals Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 34. Orexigen Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Orexigen Therapeutics Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 36. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Johnson & Johnson Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 38. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Pfizer Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 40. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Novartis AG Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 42. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Biocon Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 44. VIVUS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. VIVUS Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 46. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Eli Lilly Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 48. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Amgen Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 50. Zafgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Zafgen Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 52. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Roche Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 54. Eisai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Eisai Revenue Growth Rate in Weight Loss Therapeutics Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
